Search This Blog

Thursday, December 8, 2022

AcelRx Publishes on Sublingual Sufentanil Tablets For Post-Operative Pain Management

 Patients reported lower pain scores, required fewer rescue doses and had a shorter hospital stay than patients receiving continuous femoral nerve block

This study of patients following knee replacement surgery adds to a growing database supporting the benefits of using sufentanil sublingual tablets for surgical pain management

https://finance.yahoo.com/news/acelrx-pharmaceuticals-announces-european-peer-133000091.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.